https://stdjhs.scienceandtechnology.com.vn/index.php/stdjhs <p><strong>The Science and Technology Development Journal - Health Sciences (STDJ-HS) (ISSN&nbsp;2734-9446)</strong> is an international, open access, and peer-reviewed journal published by School of Medicine, Vietnam National University Ho Chi Minh City. The journal publishes researches in the fields of medicine, pharmacy, dentistry, public health, traditional medicine, nursing, and medical technology. Relevant articles from other disciplines of health professions may be considered for publication. However, the journal places an emphasis on publishing high-quality, high-impact and novel research. Articles can be submitted in the in the form of original research articles, reviews, case reports, commentaries or letters to the editor. We accept manuscripts in both English and Vietnamese.</p> <p><span id="result_box" class="" lang="en"><span title="Tạp chí đã trải qua 20 năm phát triển và đã trở thành nhịp cầu giao lưu khoa học, cũng như làm phong phú tài liệu tham khảo cho đội ngũ giảng viên, nghiên cứu sinh, sinh viên ĐHQG-HCM nói riêng và các Trường đại">&nbsp;</span></span></p> <p>&nbsp;</p> <p><span class="" lang="en"><span title="Tạp chí đã trải qua 20 năm phát triển và đã trở thành nhịp cầu giao lưu khoa học, cũng như làm phong phú tài liệu tham khảo cho đội ngũ giảng viên, nghiên cứu sinh, sinh viên ĐHQG-HCM nói riêng và các Trường đại"><span id="result_box" class="" lang="en"><span title="Tạp chí Phát triển Khoa học và Công nghệ (PTKH&amp;CN) của Đại học Quốc gia thành phố Hồ Chí Minh (ĐHQG-HCM) được thành lập từ năm 1997, ra số đầu tiên vào tháng 1 năm 1998. Từ năm 2006 Tạp chí đã"><strong>Science and Technology Development Journal - Health Sciences (STDJ-HS) is a subjournal of Science and Technology Development Journal focusing on:</strong><br></span></span></span></span></p> <p>&nbsp;</p> <ul> <li class="show">Publishing articles with contents on healthcare, research projects in the field of health, advanced directions in health education and management. Therefore, STDJ-HS will accept articles from doctors, administrators, teachers, researchers, graduate students and fellows. The authors will be responsible for the accuracy of the data, opinions, opinions and material cited in the article.</li> <li class="show">Facilitating the exchange of scientific and technological information and act as a bridge between theory and practice in the community of educators, scientists, managers, policy makers and enterprises in and out of the country.</li> </ul> <p><span class="" lang="en"><span title="• Khoa học Trái đất và Môi trường"><span id="result_box" class="" lang="en">&nbsp;</span></span></span></p> Viet Nam National University Ho Chi Minh City en-US Science and Technology Development Journal: Health Sciences 2734-9446 <p>Copyright The Author(s) 2018. This article is published with open access by Vietnam National University, Ho Chi Minh city, Vietnam. This article is distributed under the terms of the&nbsp;<a href="https://creativecommons.org/licenses/by/4.0/" target="_blank" rel="noopener">Creative Commons Attribution License (CC-BY 4.0)</a> which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.&nbsp;</p> https://stdjhs.scienceandtechnology.com.vn/index.php/stdjhs/article/view/572 <p>Dravet syndrome is a developmental epileptic encephalopathy characterized by early onset drug-resistant seizures and other clinical features, including intellectual disability and impairments in behavior, motor, and sleep which cause poor quality of life and impact the long-term course. The pathogenesis of Dravet syndrome is strongly connected to the dysfunction of the voltage-gated sodium channel, more specifically, to mutations in SCN1A gene. Epilepsy in Dravet syndrome is very refractory and seizures remain poorly controlled even with multiple conventional anti-epileptic drugs. Therapeutic approaches in Dravet syndrome have undergone tremendous changes in the lastest years and the current consensus of seizure management strategy in Dravet syndrome consists of a combination of conventional drugs and three recently approved drugs including stiripentol, cannabidiol, and fenfluramine. This review article aims to update recent changes to the therapeutic landscape for Dravet syndrome by summarizing the most key data from the clinical development of stiripentol, cannabidiol, and fenfluramine. This article also reviews and discusses the latest findings of other pharmacotherapies in development, including serotonergic agents, soticlestat, verapamil as well well strategies to treat the underlying cause of Dravet syndrome, including gene therapy and antisense oligonucleotides.</p> Hang Thi Thu Do ##submission.copyrightStatement## http://creativecommons.org/licenses/by/4.0 2024-06-30 2024-06-30 5 1 633 643 10.32508/stdjhs.v4i2.572 title description none g https://stdjhs.scienceandtechnology.com.vn/index.php/stdjhs/article/view/577 <p>Purpose: To investigate the epidemiological, clinical, microbiological characteristics and antibiotic resistance profile in patients with bacterial corneal ulcers at Ho Chi Minh City Eye Hospital in 2020. Methods: An observational retrospective study was conducted on 242 cases diagnosed with bacterial corneal ulcers examined at Ho Chi Minh City Eye Hospital from January 2020 to December 2020. Information about patients’ medical history, clinical symptoms, and test results was collected from medical records. Results: Bacterial keratitis was more often seen in males and in middle-age group. Injury as a risk factor accounted for a considerable proportion of cases (24,4%). Self-treatment was common (23,1%). The culture results were mainly Gram-positive (56,6%), in which coagulase-negative staphylococci (49,2%) predominates. Pseudomonas aeruginosa (26,9%) was the most common Gram-negative pathogen. The resistance rate of coagulase-negative staphylococci to common antibiotics, including fluoroquinolones group, was relatively high (50,0 – 100,0%). Meanwhile, P.aeruginosa was sensitive to many fluoroquinolones, as well as to tobramycin and ceftazidime. Notably, we recorded twelve cases of resistance to all tested antibiotics. The rate of visual acuity improvement at the time of discharge was still unfavorably low (5,8%). There were 43,0% of patients experiencing at least one serious complication: increased intraocular pressure, endophthalmitis, impending perforation and perforation of the cornea. Up to 11,6% of patients had to resort to enucleation. Conclusions: Corneal ulceration related to trauma accounted for a significant percentage. Self-medication was still common. The high rate of antibiotic resistance along with the appearance of numerous multi-drug resistance cases is very worrying. Severe consequences were left upon patients’ eyesight.</p> Bao Hong Tran Huy Hoàng Lê An Dang Phan Hung Thai Pham Loc Huu Nguyen Phuc Thi Diem Tran Huan Nguyen Pham ##submission.copyrightStatement## http://creativecommons.org/licenses/by/4.0 2024-06-30 2024-06-30 5 1 624 632 10.32508/stdjhs.v5i1.577 title description none g